Andrew Bowler

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Silver - Individuals: litigation

Although perhaps best known for the shrewd and tenacious approach it takes to patent litigation across the life sciences and SEP and FRAND cases in the tech field, Bristows also boasts clever and skilled transactions specialists. Matthew Warren heads the commercial IP group, supported by Richard Dickinson and Claire Smith. “Matthew is an excellent lawyer and fully understands the needs of research institutions when licensing IP to commercial third parties. He is highly recommended for patent transactions.” “Richard makes really valuable contributions to pharmaceutical licensing discussions. He is pragmatic, business oriented and readily available when needed.” Smith provides a unique commercial perspective to life sciences work, accrued through her time spent working for Abbott Laboratories’ medical device business. Her advice is unfailingly business sensitive and always pragmatic. On the contentious front, one of the United Kingdom’s best-known names in the field of patent litigation is Dominic Adair. As one client puts it: “Dom and the Bristows team are true experts when it comes to patent litigation. Dom has deep knowledge, is highly approachable and adaptive to circumstances. He is able to dial up or down depending on the situation – presenting equal dexterity in no-stone-unturned approaches as in negotiating pragmatic solutions. He and his team are all stand-out professionals. Bristows is a technical IP one-stop shop and a true centre of excellence.” Myles Jelf, co-head of the patent litigation practice, led one of 2021’s most-watched patent cases – successfully appealing a controversial Crown Use defence decision for IPCom against Vodafone. His participation in the groundbreaking Unwired Planet case makes him one of the United Kingdom’s most high-profile litigators in the high-tech patent space. The other co-head of the litigation team is Andrew Bowler. “Andrew is very well experienced in pan-European patent enforcement. He offers up canny and creative strategies and is skilled in managing local counsel. On top of it all, he’s enjoyable to work with.” The other two names to know on the technology side are James Boon and Richard Pinckney. Boon’s doctorate in physics gives him technical savvy in most technologies, while he has cultivated legal expertise in the intersection of IP and competition law – together these attributes make him a smart choice for FRAND and SEP issues. Pinckney offers similar expertise and has represented some of the world’s biggest and most valuable companies in high-tech patent litigation, often related to FRAND issues. For life sciences patrons, Bristows boasts a very well-stocked, technically proficient and experienced bench of practitioners. With a doctorate in neuroscience, Gregory Bacon has keen insight into technical issues in the life sciences. He has advised companies across the industry, but is equally deft at handling technologies in other fields, from software and online publishing to shipping. Another life science specialist is Gemma Barrett, whom clients describe as “a brilliant and highly passionate patent litigator with an in-depth understanding of the complex legal and technical details of her cases. She is very efficient and responsive and always provides excellent strategic and legal advice, often within very tight timelines.” Highly experienced in coordinating cross-jurisdictional patent litigation, Robert Burrows is as organised and legally astute as he is technically confident. A background in genetics means he can speak the same language as his life science clientele. Liz Cohen has over 20 years of experience and is highly sought after for her relevant, commercially savvy and technically polished advice. A noted authority on litigation law, she tutors on the Oxford University Diploma in Intellectual Property in patent litigation. Nearing 30 years in practice, Brian Cordery is another authority on life sciences patent litigation, especially in the pharmaceutical sector. Cordery’s exceptional understanding of biological medicines, together with a strategic overview of the litigation landscape, has been vital to the firm’s longstanding relationship with Teva, for which Cordery acts together with Burrows and Rachel Mumby. An accomplished litigator with a chemistry background, Mumby manages the relationship with Novartis. Together with others in the group, including Bacon and Cordery, Mumby has assisted Novartis on various cases in the English High Court, generally helping to maintain a robust and secure enforcement strategy.

Unlock unlimited access to all IAM content